Spectrum Pharmaceuticals
Innovative solutions driving advancements in cancer treatment through strategic development and commercialization of unique therapeutic products.
Innovative solutions driving advancements in cancer treatment through strategic development and commercialization of unique therapeutic products.
Spectrum Pharmaceuticals is a biopharmaceutical company founded in 1987, with a focus on acquiring, developing, and commercializing innovative and targeted drug products within the field of oncology. The company's slogan emphasizes its commitment to driving advancements in cancer treatment through strategic development and commercialization of unique therapeutic products. Spectrum Pharmaceuticals has established an impressive track record in in-licensing and acquiring unique drugs, as well as in clinical development. Its last investment of $30.00M, a Post-IPO Debt investment, was made on 23 September 2022 and was led by SLR Capital Partners. The company operates within the industries of Biopharma, Biotechnology, and Health Care.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Debt | $30.00M | 1 | SLR Capital Partners | 23 Sep 2022 |
| Post-IPO Equity | $20.00M | 1 | Hanmi Pharmaceutical | 04 Jan 2022 |
| Post-IPO Equity | $65.00M | - | 29 Jul 2020 | |
| Post-IPO Equity | $3.00M | - | 29 Apr 2016 | |
| Grant | $977.90K | - | 03 Nov 2010 |
No recent news or press coverage available for Spectrum Pharmaceuticals.
We care about your data, and we'd love to use cookies make your experience better.
